Arpeggio Bio
Arpeggio Bio develops drugs targeting transcription factors using AI…
Operating in healthcare based in Boulder, CO, USA, Arpeggio Bio was founded in 2017.
Profile
Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma. With partnerships with J&J and FORMA, we've validated our platform in rare disease and inflammation with a significant Phase I success.
Its activity falls under healthcare; the profile below is assembled from public directory data.
Boulder, CO, USA is where the company is located.
Directory data places it at the Summer 2019 stage.
Its team size is recorded as 20 employees.
| Sector | Healthcare |
|---|---|
| Headquarters | Boulder, CO, USA |
| Country | USA |
| Founded | 2017 |
| Employees | 20 |
| Stage | Summer 2019 |
Website: www.arpeggiobio.com
Browse related
Create a free account